Smith Nicholas Conrad bought ANRO
March 1, 2024 · Form 4 insider transaction
Smith Nicholas Conrad bought 19,153 shares of Alto Neuroscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,153
Price
$0.00
Total value
N/A
InsiderSmith Nicholas Conrad
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 1, 2024
Filing dateMarch 5, 2024
Shares owned after20,716
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. The RSUs shall vest in two equal installments on September 1, 2025 and March 1, 2026, subject to the Reporting Person's continuous service through each such vesting date.; Each RSU represents a contingent right to receive one share of common stock.